For: | Yu MM, Feng YH, Zheng L, Zhang J, Luo GH. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells. World J Gastroenterol 2019; 25(10): 1210-1223 [PMID: 30886504 DOI: 10.3748/wjg.v25.i10.1210] |
---|---|
URL: | https://www.wjgnet.com/1949-8470/full/v25/i10/1210.htm |
Number | Citing Articles |
1 |
James Saliba, Baptiste Coutaud, Kiran Makhani, Noam Epstein Roth, Jennie Jackson, Joo Yeoun Park, Natascha Gagnon, Paolo Costa, Thiviya Jeyakumar, Marina Bury, Nicole Beauchemin, Koren K. Mann, Volker Blank. Loss of NFE2L3 protects against inflammation-induced colorectal cancer through modulation of the tumor microenvironment. Oncogene 2022; 41(11): 1563 doi: 10.1038/s41388-022-02192-2
|
2 |
Effi Haque, M. Rezaul Karim, Aamir Salam Teeli, Magdalena Śmiech, Paweł Leszczynski, Dawid Winiarczyk, Emil D. Parvanov, Atanas G. Atanasov, Hiroaki Taniguchi. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis. International Journal of Molecular Sciences 2020; 21(15): 5378 doi: 10.3390/ijms21155378
|
3 |
Anni Immonen, Kirsi-Maria Haapasaari, Sini Skarp, Peeter Karihtala, Hanna-Riikka Teppo, Sander Bekeschus. NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/2240223
|
4 |
Ping Xing, Zhenzhen Chen, Wenbo Zhu, Bangyi Lin, Mingming Quan. NRF3 suppresses the malignant progression of TNBC by promoting M1 polarization of macrophages via ROS/HMGB1 axis. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2416221
|
5 |
Mengxiao Liu, Hui Wei, Jing Yang, Xia Chen, Haoying Wang, Ya Zheng, Yuping Wang, Yongning Zhou. Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.916973
|
6 |
Haixiang Xue, Miaomei Yu, Ying Zhou, Jun Zhang, Qinfeng Mu, Tongbing Chen, Guanghua Luo, Jisheng Liu. Apolipoprotein M inhibits proliferation and migration of larynx carcinoma cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-76480-w
|
7 |
Xiaodong Wang, Yaxian Li, Ziqing Fang, Yongxiang Li. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation. Bioengineered 2021; 12(2): 12204 doi: 10.1080/21655979.2021.2005915
|
8 |
Akira Kobayashi. Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors. Cancers 2020; 12(9): 2681 doi: 10.3390/cancers12092681
|
9 |
Yonggang Ren, Jing Yang, Zhiran Ding, Menghua Zheng, Lu Qiu, Aifa Tang, Dandan Huang. NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome‐dependent degradation of ISGylated p53. Cancer Science 2023; 114(9): 3523 doi: 10.1111/cas.15887
|
10 |
Guanghui Xiong, Jie Li, Fuli Yao, Fang Yang, Yuancai Xiang. New insight into the CNC-bZIP member, NFE2L3, in human diseases. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1430486
|
11 |
Mei Yang, Menghui Wang, Nanfang Li. Advances in pathogenesis of preeclampsia. Archives of Gynecology and Obstetrics 2024; 309(5): 1815 doi: 10.1007/s00404-024-07393-6
|